Fund HoldingsSarissa Capital Management LP

Total Portfolio Value
$571.63M
Total Bought
$27.77M
Total Sold
$14.15M
Net Transaction
+$13.62M
Filing Period:
Securities
SharesValue ($K)
Q4 2023
Q1 2024
Change
Q4 2023
Q1 2024
Weight (%)
Change
CYTOKINETICS INC(CYTK)0300,000+300,000021,0333.68%+21,033
AMARIN CORP PLC24,850,62324,850,623021,62022,1373.87%+517
REGULUS THERAPEUTICS INC185,183185,18302375330.09%+296
VOR BIOPHARMA INC(VOR)618,000618,00001,3911,4650.26%+74
BIOCRYST PHARMACEUTICALS INC(BCRX)1,000,0001,094,168+94,1685,9905,5580.97%-432
INNOVIVA INC(INVA)7,277,0007,277,0000116,723110,90119.40%-5,822
GILEAD SCIENCES INC(GILD)1,075,4001,103,282+27,88287,11880,81514.14%-6,303
NEUROCRINE BIOSCIENCES INC(NBIX)470,000346,426-123,57461,92747,7798.36%-14,148
BIOGEN INC(BIIB)643,000643,0000166,389138,65024.26%-27,739
IRONWOOD PHARMACEUTICALS INC16,390,00016,390,0000187,502142,75724.97%-44,745
Page 1 of 1